Michael J Gonzalez to Vitamins
This is a "connection" page, showing publications Michael J Gonzalez has written about Vitamins.
Connection Strength
0.973
-
Gonz?lez MJ, Miranda-Massari JR, Duconge J. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later: comment on the article by Cabanillas. P R Health Sci J. 2010 Dec; 29(4):410-1; author reply 411-2.
Score: 0.356
-
Gonz?lez MJ, Ricart CM, Miranda-Massari J. A vitamin, mineral, herb dietary supplement effect on blood glucose in uncontrolled type II diabetic subjects. P R Health Sci J. 2004 Jun; 23(2):119-20.
Score: 0.227
-
Gonz?lez MJ, Miranda-Massari JR, Duconge J, Allende-Vigo MZ, Jim?nez-Ram?rez FJ, Cintr?n K, Rodr?guez-G?mez JR, Rosario G, Ricart C, Santiago-Cornier JA, Zaragoza-Urdaz R, V?zquez A, Hickey S, Jabbar-Berdiel M, Riordan N, Ichim T, Santiago O, Alvarado G, Vora P. Metabolic correction: a functional biochemical mechanism against disease--Part 1: concept and historical background. P R Health Sci J. 2015 Mar; 34(1):3-8.
Score: 0.119
-
Gonzalez MJ, Miranda-Massari JR. Diet and stress. Psychiatr Clin North Am. 2014 Dec; 37(4):579-89.
Score: 0.116
-
Riordan HD, Casciari JJ, Gonz?lez MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005 Dec; 24(4):269-76.
Score: 0.063
-
Gundra UM, Girgis NM, Gonzalez MA, San Tang M, Van Der Zande HJP, Lin JD, Ouimet M, Ma LJ, Poles J, Vozhilla N, Fisher EA, Moore KJ, Loke P. Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation. Nat Immunol. 2017 06; 18(6):642-653.
Score: 0.035
-
Miranda-Massari JR, Gonz?lez MJ, Rodriguez-Gomez JR, Duconge J, Allende-Vigo MZ, Jim?nez Ramirez FJ, Cintr?n K, Ricart C, Zaragoza-Urdaz R, Berdiel MJ, V?zquez A. [Metabolic correction: a biochemical option against diseases]. Bol Asoc Med P R. 2015 Apr-Jun; 107(2):60-6.
Score: 0.030
-
Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al-Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J, Hughes I, McCullagh BG, Jungbluth H, Lim MJ, Lin JP, Megarbane A, Urtizberea JA, Shah AH, Antony J, Webster R, Broomfield A, Ng J, Mathew AA, O'Byrne JJ, Forman E, Scoto M, Prasad M, O'Brien K, Olpin S, Oppenheim M, Hargreaves I, Land JM, Wang MX, Carpenter K, Horvath R, Straub V, Lek M, Gold W, Farrell MO, Brandner S, Phadke R, Matsubara K, McGarvey ML, Scherer SS, Baxter PS, King MD, Clayton P, Rahman S, Reilly MM, Ouvrier RA, Christodoulou J, Z?chner S, Muntoni F, Houlden H. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan; 137(Pt 1):44-56.
Score: 0.027